NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

“Only if the MHRA approves DCVax-L and NWBO secures non-dilutive financing (possibly preceding a buyout or speculation about one) will the company survive.”

— Agreed. Both are important. UK approval only without non dilutive financing will still enable the company to survive for a few years. They will continue to trap bag holders as they have been doing for years, but ultimately there will be another 90% drop in the share price and the market cap drops to under well under $100M with all the increase in outstanding shares in 2026 and beyond.

On the other hand, if the UK application is rejected the shares pretty much go under .01 in no time. And then bankruptcy in a few days.